Cite
HARVARD Citation
Faissner, S. et al. (2020). Endocarditis following ocrelizumab in relapsing-remitting MS. Neurology. 7 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Faissner, S. et al. (2020). Endocarditis following ocrelizumab in relapsing-remitting MS. Neurology. 7 (3), p. . [Online].